InsiderTrades

Form 4 for INGN Inogen Inc

Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0001193125-25-305251 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-02 2025-12-01 INGN Smith Kevin Raymond Merrill CEO, Pres, Dir M - OptEx $0.00 +28.3K 100.1K +39% $0
D 2025-12-02 2025-12-01 INGN Smith Kevin Raymond Merrill CEO, Pres, Dir F - Tax $6.95 -13.8K 86.3K -14% -$96.0K
D 2025-12-02 2025-12-01 INGN Smith Kevin Raymond Merrill CEO, Pres, Dir M - OptEx $0.00 -28.3K 28.3K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-01 M A 28,334 $0.00 100,108 D — —
2 Common Common Stock 2025-12-01 F D 13,817 $6.95 86,291 D — — (F1) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2025.
3 Derivative Restricted Stock Unit 2025-12-01 M D 28,334 $0.00 28,333 D — · — to — 28,334 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F3) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.